Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

Kozlitina, Julia, Smagris, Eriks, Stender, Stefan, Nordestgaard, Børge G, Zhou, Heather H, Tybjærg-Hansen, Anne, Vogt, Thomas F, Hobbs, Helen H +1 more·2014·Nature Genetics

DOI 10.1038/ng.2901

Cited by (1,001)

Items 601–700 of 1,001

Racial Disparities in Liver Disease Mortality Trends Among Black and White Populations in the United States, 1999–2020: An Analysis of CDC WONDER Database
Yichen Wang, Yuting Huang, Samuel O. Antwi, C. Burcin Taner, Liu Yang · 2023 · The American Journal of Gastroenterology
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention
Lawan Rabiu, Pengchao Zhang, L. O. Afolabi, M. Saliu, Salisu M. Dabai, R. B. Suleiman, Khalid I Gidado, M. A. Ige, Abdulrahman Ibrahim, Gui-Zhong Zhang et al. · 2024 · Journal of gastroenterology
Liver fibrogenesis: un update on established and emerging basic concepts
Erica Novo, Claudia Bocca, Beatrice Foglia, Francesca Protopapa, Marina Maggiora, Maurizio Parola, Stefania Cannito · 2020 · Archives of Biochemistry and Biophysics
NAFLD-related HCC.
B. Banini, A. Sanyal · 2021 · Advances in Cancer Research
Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals
Charlotte Näslund‐Koch, Stig E. Bojesen, Lise Lotte Gluud, Lone Skov, Signe Vedel‐Krogh · 2022 · Frontiers in Immunology
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting
Alina M. Allen, Michael Charlton, Kenneth J. Cusi, Stephen A. Harrison, Kris V. Kowdley, Mazen Noureddin, Jay H. Shubrook · 2024 · Postgraduate Medicine
Recent developments in genome and exome-wide analyses of plasma lipids
Leslie A. Lange, Cristen J. Willer, Stephen S. Rich · 2015 · Current Opinion in Lipidology
Nonalcoholic steatohepatitis, obesity, and cardiac dysfunction
Sherin Elsa Mathews, Rekha B. Kumar, Alpana P. Shukla · 2018 · Current Opinion in Endocrinology Diabetes and Obesity
Mechanisms, biomarkers and targets for therapy in alcohol-associated liver injury: From Genetics to nutrition: Summary of the ISBRA 2018 symposium
Irina Kirpich, Dennis Ray Warner, Wenke Feng, Swati Joshi‐Barve, Craig James McClain, Devanshi Seth, Wei Hong Zhong, Zhanxiang Zhou, Natalia A. Osna, Kusum K. Kharbanda · 2019 · Alcohol
The Rise in the Prevalence of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
Zaki A. Sherif · 2019 · IntechOpen eBooks
Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma
P. Nahon, M. Allaire, J. Nault, V. Paradis · 2020 · Hepatic Oncology
Molecular Regulation and Therapeutic Targeting of VLDL Production in Cardiometabolic Disease
Kendall H. Burks, Nathan O. Stitziel, Nicholas O. Davidson · 2024 · Cellular and Molecular Gastroenterology and Hepatology
Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunctionassociated steatotic liver disease
Eiji Kakazu, Masaaki Mino, Tatsuya Kanto · 2025 · Clinical and Molecular Hepatology
Metabolic and genetic mechanisms of metabolic dysfunction-associated steatotic liver disease: an integrative perspective from molecular pathways to clinical challenges
Jingyuan Ma, Yanfen Ma, Xing Wan, Junchen Li, Yunshu Zhang, Jifeng Liu, Yunhai Gao · 2025 · Frontiers in Endocrinology
Caspase-12, but Not Caspase-11, Inhibits Obesity and Insulin Resistance
Alexander M. Skeldon, Alexandre Morizot, Todd Douglas, Nicola Santoro, Romy Kursawe, Julia Kozlitina, Sonia Caprio, Wajahat Zafar Mehal, Maya Saleh · 2015 · The Journal of Immunology
Active p38α causes macrovesicular fatty liver in mice
Ilona Darlyuk‐Saadon, Chen Guang Bai, Chew Kiat Matthew Heng, Nechama Gilad, Weiping Yu, Pei Yen Lim, Amaury Cazenave‐Gassiot, Yongliang Zhang, W.S. Fred Wong, David Engelberg · 2021 · Proceedings of the National Academy of Sciences
Non-alcoholic Fatty Liver Disease in Children
Emir M. Muzurović, Stergios A. Pοlyzos, Dimitri P. Mikhailidis, Sanja Borozan, Dušanka Novosel, Oleg Cmiljanić, Nataša Kadić, Christos Socrates Mantzoros · 2022 · Current Vascular Pharmacology
Exome-wide association analysis of CT imaging-derived hepatic fat in a medical biobank
Joseph Park, Matthew T. MacLean, Anastasia Lucas, Drew A. Torigian, Carolin Victoria Schneider, Tess Cherlin, Brenda Xiao, Jason E. Miller, Yuki Bradford, Renae Judy et al. · 2022 · Cell Reports Medicine
Genetic and Metabolic Characteristics of Lean Nonalcoholic Fatty Liver Disease in a Korean Health Examinee Cohort
Huiyul Park, Eileen Laureal Yoon, Goh Eun Chung, Eun Kyung Choe, Jung Ho Bae, Seung Ho Choi, Mimi Kim, Woochang Hwang, Hye‐Lin Kim, Sun Young Yang et al. · 2023 · Gut and Liver
Practical approach to non‐alcoholic fatty liver disease in patients with diabetes
Foong Way David Tai, Wing‐Kin Syn, William Alazawi · 2015 · Diabetic Medicine
A Large-Scale, Exome-Wide Association Study of Han Chinese Women Identifies Three Novel Loci Predisposing to Breast Cancer
Bo Zhang, Men-Yun Chen, Yu-Jun Shen, Xian-Bo Zhuo, Ping Hui Gao, Fu-Sheng Zhou, Bo Liang, Jun Zu, Qin Zhang, Sufyan Suleman et al. · 2018 · Cancer Research
Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study)
Aki Juhani Käräjämäki, Janne Hukkanen, Heikki Kauma, Y. Antero Kesäniemi, Olavi H. Ukkola · 2019 · Scandinavian Journal of Clinical and Laboratory Investigation
The Nuclear Envelope in Lipid Metabolism and Pathogenesis of NAFLD
Cecilia Östlund, Antonio Hernández‐Ono, Ji‐Yeon Shin · 2020 · Biology
Genetic risk factors associated with NAFLD
Dong Yun Kim, Jun Yong Park · 2020 · Hepatoma Research
Functional compartmentalization of hepatic mitochondrial subpopulations during MASH progression
Noble Kumar Talari, Ushodaya Mattam, Afra P. Rahman, Brook K. Hemmelgarn, Michael A. Wyder, Pamela B. Sylvestre, Kenneth D. Greis, Karthickeyan Chella Krishnan · 2025 · Communications Biology
Polygenic Risk Score for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Narrative Review
Tatsuo Kanda, Reina Sasaki, Hiroyuki Abé, Naruhiro Kimura, Tomoaki Yoshida, Kazunao Hayashi, Akira Sakamaki, Takeshi Yokoo, Hiroteru Kamimura, Atsunori Tsuchiya et al. · 2025 · International Journal of Molecular Sciences
Genetic and non-genetic drivers of histological progression and regression in MASLD
Eduardo Vilar Gómez, Katherine P. Yates, David Erwin Kleiner, Cynthia A. Behling, Oscar W. Cummings, Laura Wilson, Tiebing Liang, Chaowapong Jarasvaraparn, Rohit Loomba, Jeffrey B. Schwimmer et al. · 2025 · Journal of Hepatology
Circulating MicroRNA‐122 and Fibrosis Stage Predict Mortality of Japanese Patients With Histopathologically Confirmed NAFLD
Norio Akuta, Yusuke Kawamura, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yoshiyuki Suzuki et al. · 2019 · Hepatology Communications
Lipid Droplet-Associated Factors, PNPLA3, TM6SF2, and HSD17B Proteins in Hepatopancreatobiliary Cancer
Yoshiaki Sunami, Artur Rebelo, Jorg H. Kleeff · 2021 · Cancers
Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review
Huimin Zou, Ying Ge, Qing Lei, Carolina Oi Lam Ung, Zhen Ruan, Yunfeng Lai, Dongning Yao, Hao Hu · 2022 · Hepatology International
Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis
Pablo Gabriel-Medina, Roser Ferrer, Francisco Rodríguez‐Frias, Andreea Ciudin, Salvador Augustín, Jesús Rivera‐Esteban, Juan Manuel Pericàs, David M. Selva · 2022 · Biomedicines
Noninvasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?
Ahilan Arulanandan, Rohit Seth Loomba · 2015 · Current Hepatology Reports
New Perspectives in Pediatric Nonalcoholic Fatty Liver Disease: Epidemiology, Genetics, Diagnosis, and Natural History
Jae Sung Ko · 2019 · Pediatric Gastroenterology Hepatology & Nutrition
Omics‐derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases
Naoto Fujiwara, Tongqi Qian, Bhuvaneswari Koneru, Yujin Hoshida · 2020 · Hepatology Research
Pharmacogenomic and Personalized Approaches to Tackle Nonalcoholic Fatty Liver Disease
Gregor Lorbek, Žiga Urlep, Damjana Rozman · 2016 · Pharmacogenomics
The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro
Pillai, S, Duvvuru, S, Bhatnagar, P, Foster, W, Farmen, M, Shankar, S, Harris, C, Bastyr, E, Hoogwerf, B, Haupt, A · 2018 · The Pharmacogenomics Journal
Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation
Ester Ciociola, Tanmoy Dutta, Kavitha Sasidharan, Lohitesh Kovooru, Francesca Rita Noto, Grazia Pennisi, Salvatore Petta, Angela Mirarchi, Samantha Maurotti, Bernadette Scopacasa et al. · 2024 · Clinical and Molecular Hepatology
Genetic Variation in the Mitochondrial Glycerol‐3‐Phosphate Acyltransferase Is Associated With Liver Injury
Aaron Hakim, Matthew R. Moll, Joseph Brancale, Jiangyuan Liu, Jessica Ann Lasky-Su, Edwin K. Silverman, Sílvia Vilarinho, Zhenghui Gordon Jiang, Yered H. Pita-Juárez, Ioannis S. Vlachos et al. · 2021 · Hepatology
Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges
Robert Hegarty, Eirini Kyrana, Emer Fitzpatrick, Anil Kumar Dhawan · 2023 · Therapeutic Advances in Endocrinology and Metabolism
Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
Georgiana-Emmanuela Gîlcă-Blanariu, Daniela Simona Budur, Dana Mitrică, Elena Gologan, Oana Timofte, Gheorghe Gh Bălan, VASILE-ANDREI OLTEANU, Gabriela Ștefănescu · 2023 · Metabolites
Genetics of liver disease in adults
Chigoziri Konkwo, Shanin Chowdhury, Sílvia Vilarinho · 2024 · Hepatology Communications
Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction–Associated Steatotic Liver Diseases: A Pathway to Precision Medicine
Xiang Zhang, Kyong‐Mi Chang, Jun Qing Yu, Rohit Seth Loomba · 2025 · Annual Review of Pathology Mechanisms of Disease
Exome-wide scan identifies significant association of rs4788084 in IL27 promoter with increase in hepatic fat content among Indians
Ankita Chatterjee, Analabha Basu, Kausik Das, Abhijit Chowdhury, Priyadarshi Basu · 2021 · Gene
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease
Mayada Metwally, Ali Bayoumi, Anis Khan, Leon Anton Adams, R. Aller, Carmelo García‐Monzón, M. Arias, Elisabetta Bugianesi, Luca Miele, Anna Alisi et al. · 2021 · EBioMedicine
Alcoholic Liver Disease
Mack C. Mitchell, Gyöngyi Szabó · 2017 · Wiley eBooks
Exploring the genetic basis of fatty liver development in geese
Yunzhou Yang, Huiying Wang, Guangquan Li, Yi Liu, Cui Wang, Daqian He · 2020 · Scientific Reports
Liver Steatosis: A Marker of Metabolic Risk in Children
Costanza Renata Neri, Serena Scapaticci, Francesco Chiarelli, Cosimo Giannini · 2022 · International Journal of Molecular Sciences
Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?
Athanasia Mitsala, Christos Tsalikidis, Κonstantinos Romanidis, Michail S. Pitiakoudis · 2022 · Current Oncology
MTARC1 and HSD17B13 Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery
Piotr Kalinowski, Wiktor Smyk, Małgorzata Nowosad, Rafał Paluszkiewicz, Łukasz Michałowski, Bogna Ziarkiewicz‐Wróblewska, Susanne Nicole Weber, Piotr Milkiewicz, Frank Lammert, Krzysztof Zieniewicz et al. · 2022 · International Journal of Molecular Sciences
New concept in fatty liver diseases
Katsutoshi Tokushige · 2023 · Hepatology Research
Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights
Fereshteh Rahdan, Alihossein Saberi, Neda Saraygord‐Afshari, Morteza Hadizadeh, Tahura Fayeghi Arjmand, Elham Ghanbari, Hassan Dianat‐Moghadam, Effat Alizadeh · 2024 · Heliyon
TM 6 SF 2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C
Salvatore Petta, Marcello Fabio Maida, Stefania Grimaudo, Rosaria Maria Pipitone, Fabio Salvatore Macaluso, Daniela Cabibi, Calogero Cammà, Vito Di Marco, Sandro Sferrazza, Antonio Craxı̀ · 2015 · Liver International
Low-frequency germline variants across 6p22.2–6p21.33 are associated with non-obstructive azoospermia in Han Chinese men
Bixian Ni, Yuan Lin, Liangdan Sun, Meng Zhu, Zheng Li, Hui Wang, Jun Jian Yu, Xuejiang Guo, Xianbo Zuo, Jing Dong et al. · 2015 · Human Molecular Genetics
The Genetics of Clinical Liver Diseases: Insight into the TM6SF2 E167K Variant
Xiaoyu Zhang, Shousheng Liu, Quanjiang Dong, Yongning Xin, Shiying Xuan · 2018 · Journal of Clinical and Translational Hepatology
European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationale
Jake Peter Mann, Anita C. E. Vreugdenhil, Piotr Socha, Wojciech Jańczyk, Ulrich Baumann, Sanjay R. Rajwal, Thomas Casswall, Claude Marcus, Indra van Mourik, Stephen O’Rahilly et al. · 2018 · Contemporary Clinical Trials
A PNPLA3 Polymorphism Confers Lower Susceptibility to Incident Diabetes Mellitus in Subjects With Nonalcoholic Fatty Liver Disease
Seoil Moon, Goh Eun Chung, Sae Kyung Joo, Jeong Hwan Park, Mee Soo Chang, Ji Won Yoon, Bo Kyung Koo, Won Kyum Kim · 2021 · Clinical Gastroenterology and Hepatology
Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik Dhanani, Swaroopa Madhuri Rath · 2021 · Cureus
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption
Rosellina Margherita Mancina, Flaminia Ferri, Alessio Farcomeni, Antonio Molinaro, Angela Maffongelli, Monica Mischitelli, Edoardo Poli, Lucia Parlati, Maria Antonella Burza, Adriano De Santis et al. · 2019 · The Application of Clinical Genetics
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism
Liu, Jing, Ginsberg, Henry N., Reyes-Soffer, Gissette · 2024 · Current Opinion in Lipidology
Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse
Ēriks Šmagris, Lisa M. Shihanian, Ivory J. Mintah, Parnian Bigdelou, Yuliya Livson, Heather M. Brown, Niek Verweij, Charleen Hunt, Reid O’Brien Johnson, Tyler Greer et al. · 2024 · PLoS Genetics
Meta‐Analysis: Effects of Steatotic Liver Disease‐Associated Genetic Risk Alleles on Longitudinal Outcomes
Matthew Kubina, Vitchapong Prasitsumrit, Jarell Tan, Joo Wei Ethan Quek, Dhiraj K. Peddu, Ankit Kumar Mishra, Pojsakorn Danpanichkul, Jake Peter Mann, Eric Trépo, Stephan Buch et al. · 2025 · Alimentary Pharmacology & Therapeutics
Meta-GWAS of PCSK9 levels detects two novel loci atAPOBandTM6SF2
Janne Pott, Jesper R. Gådin, Elizabeth Theusch, Marcus Edi Kleber, Graciela E. Delgado, Holger Kirsten, Stefanie M. Hauck, Ralph Burkhardt, Hubert Scharnagl, Ronald M. Krauss et al. · 2021 · Human Molecular Genetics
Different effects of low muscle mass on the risk of non‐alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort
Hun Jee Choe, Hyunsuk Lee, Dong‐Ho Lee, Soo‐Heon Kwak, Bo Kyung Koo · 2022 · Journal of Cachexia Sarcopenia and Muscle
Hepatic COX1 loss leads to impaired autophagic flux and exacerbates nonalcoholic steatohepatitis
Qian Yu, Chang Li, Qinghui Niu, Jigang Wang, Zhaodi Che, Ke Lei, He Ren, Boyi Ma, Yixing Ren, Pingping Luo et al. · 2023 · Acta Pharmaceutica Sinica B
Longitudinal association between overweight years, polygenic risk and NAFLD, significant fibrosis and cirrhosis
Veeral H. Ajmera, Na Wang, Hanfei Xu, Ching‐Ti Liu, Michelle T. Long · 2023 · Alimentary Pharmacology & Therapeutics
Postprandial dysfunction in fatty liver disease
Josephine Grandt, Anne‐Sofie Houlberg Jensen, Mikkel Parsberg Werge, Elias Badal Rashu, Andreas Møller, Anders Ellekaer Junker, Lise Hobolth, Christian Mortensen, Christian Dall Johansen, Mogens Vyberg et al. · 2023 · Physiological Reports
Unraveling the pathogenesis of non‐alcoholic fatty liver diseases through genome‐wide association studies
Ye Tian, Bo Wang · 2023 · Journal of Gastroenterology and Hepatology
Study on inflammation and fibrogenesis in MAFLD from 2000 to 2022: a bibliometric analysis
Kuanhong Luo, Yang Chen, Shuzheng Fang, Siqi Wang, Zhixin Wu, Huiqing Li · 2023 · Frontiers in Endocrinology
The ubiquitin E3 ligase BFAR promotes degradation of PNPLA3
Avash Das, Haili Cheng, Yang Wang, Lisa N. Kinch, Guosheng Liang, Sen Hong, Helen H. Hobbs, Jonathan C. Cohen · 2024 · Proceedings of the National Academy of Sciences
Genome-wide Studies Reveal Genetic Risk Factors for Hepatic Fat Content
Yanni Li, Eline H. van den Berg, Alexander Kurilshikov, Daria V. Zhernakova, Ranko Gaćeša, Shixian Hu, Esteban A. Lopera-Maya, Alexandra Zhernakova, Lifelines Cohort Study, Raúl Aguirre‐Gamboa et al. · 2024 · Genomics Proteomics & Bioinformatics
Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist
Cristina B. Guzmán, Suman Duvvuru, Patrick Anthony Akkari, Pallav Bhatnagar, Chakib Battioui, Wendra M. Foster, Xiaotian Michelle Zhang, Sudha S. Shankar, Mark A. Deeg, Naga Chalasani et al. · 2018 · Hepatology Communications
Lipoprotein metabolism in liver diseases
Maria Camila Pérez-Matos, Bynvant Sandhu, Alan Bonder, Zhenghui Gordon Jiang · 2018 · Current Opinion in Lipidology
A variant near DHCR24 associates with microstructural properties of white matter and peripheral lipid metabolism in adolescents
Eeva Sliz, Jean Shin, Catriona A. Syme, Yash Patel, Nadine Parker, Louis Richer, Daniel Gaudet, Steffany A. L. Bennett, Tomáš Paus, Zdenka Pausová · 2020 · Molecular Psychiatry
Non-Alcoholic Fatty Liver Disease and Vascular Disease
Roberta Forlano, Benjamin Harvey Mullish, Rooshi Nathwani, Ameet Dhar, Mark R. Thursz, Pinelopi Manousou · 2020 · Current Vascular Pharmacology
Research progress on the relationship between TM6SF2 rs58542926 polymorphism and non-alcoholic fatty liver disease
Wan-Ying Xue, Li Rita Zhang, Chuanmiao Liu, Yu Gao, Shujing Li, Ziyou Huai, Jing Dai, Yuanyuan Wang · 2022 · Expert Review of Gastroenterology & Hepatology
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease
Grazia Pennisi, Rosaria Maria Pipitone, Marco Enea, Antonio De Vincentis, Salvatore L Battaglia, Vito Di Marco, Vincenzo Di Martino, Federica Spatola, Federica Tavaglione, Umberto Vespasiani Gentilucci et al. · 2022 · Hepatology Communications
Identification of deleterious rare variants in MTTP, PNPLA3, and TM6SF2 in Japanese males and association studies with NAFLD
Supichaya Boonvisut, Ken Yoshida, Kazuhiro Nakayama, Kazuhisa Watanabe, Hiroshi Miyashita, Sadahiko Iwamoto · 2017 · Lipids in Health and Disease
From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights
Gatzios, Alexandra, Rombaut, Matthias, Buyl, Karolien, De Kock, Joery, Rodrigues, Robim M., Rogiers, Vera, Vanhaecke, Tamara, Boeckmans, Joost · 2022 · Biomedicines
Consensus Statement on Metabolic Dysfunction‐Associated Steatotic Liver Disease in Children and Adolescents From the Joint TASL ‐ TSPGHAN Expert Committee
Yu‐Cheng Lin, Fang‐Min Liao, Hsun‐Ching Chao, An‐Chyi Chen, Yung‐Ming Jeng, Chieh‐Chung Lin, Mao‐Meng Tiao, Yao‐Jong Yang, Chun‐Yan Yeung, Huey‐Ling Chen et al. · 2025 · JGH Open
Replication analysis of genetic association of the NCAN-CILP2 region with plasma lipid levels and non-alcoholic fatty liver disease in Asian and Pacific ethnic groups
Supichaya Boonvisut, Kazuhiro Nakayama, Saho Makishima, Kazuhisa Watanabe, Hiroshi Miyashita, Lkhagvasuren Munkhtulga, Yasuo Kagawa, Sadahiko Iwamoto · 2016 · Lipids in Health and Disease
Towards harnessing the value of organokine crosstalk to predict the risk for cardiovascular disease in non-alcoholic fatty liver disease
Theodor Baars, Robert K. H. Gieseler, Polykarpos Patsalis, Ali E. Canbay · 2022 · Metabolism
The impact of transmembrane 6 superfamily 2 (TM6SF2) rs58542926 on liver-related events in patients with advanced chronic liver disease
Lorenz Balcar, Bernhard Scheiner, Markus Urheu, Patrick Weinberger, Rafael Paternostro, Benedikt Simbrunner, Georg Semmler, Claudia Willheim, Matthias Pinter, Péter Ferenci et al. · 2023 · Digestive and Liver Disease
Ameliorating effect of probiotic on nonalcoholic fatty liver disease and lipolytic gene expression in rabbits
Marina Aziz, Shabaan A. Hemeda, Ghadeer Mohsen Albadrani, Sabreen Ezzat Fadl, Fatma Elgendey · 2023 · Scientific Reports
Association of non-high-density lipoprotein cholesterol trajectories with the development of non-alcoholic fatty liver disease: an epidemiological and genome-wide association study
Jun-Hyuk Lee, Jiyeon Kim, Jung Oh Kim, Yu-Jin Kwon · 2023 · Journal of Translational Medicine
Mitochondrial amidoxime‐reducing component 1 p. Ala165Thr increases protein degradation mediated by the proteasome
Tanmoy Dutta, Kavitha Sasidharan, Ester Ciociola, Grazia Pennisi, Francesca Rita Noto, Lohitesh Kovooru, Tobias Kroon, Anna Lindblom, Yue Du, Mohammad Pirmoradian et al. · 2024 · Liver International
Liver at crossroads: unraveling the links between obesity, chronic liver diseases, and the mysterious obesity paradox
Maha Elsabaawy · 2024 · Clinical and Experimental Medicine
The Association between Pediatric NAFLD and Common Genetic Variants
Giuseppina Rosaria Umano, Mariangela Martino, Nicola Santoro · 2017 · Children
Transmembrane 6 superfamily member 2 167K allele improves renal function in children with obesity
Pierluigi Marzuillo, Anna Di Sessa, Grazia Cirillo, Giuseppina Rosaria Umano, Marcella Pedullà, Angela La Manna, Stefano Guarino, Emanuele Miraglia del Giudice · 2020 · Pediatric Research
Type 2 diabetes sex-specific effects associated with E167K coding variant in TM6SF2
Yanbo Fan, Brooke N. Wolford, Haocheng Lu, Wenying Liang, Jinjian Sun, Wei Zhou, Oren Rom, Anubha Mahajan, Ida L. Surakka, Sarah E. Graham et al. · 2021 · iScience
Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease
Qingfeng Sun, Liang‐Jie Tang, Mingjie Wang, Pei‐Wu Zhu, Yangyang Li, Hong‐Lei Ma, Ou‐Yang Huang, Liang L. Hong, Gang Li, Christopher D. Byrne et al. · 2022 · Frontiers in Medicine
Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring
Natalia Balassiano Wajsbrot, Nathalie Carvalho Leite, Gil Fernando Salles, Cristiane Alves Villela‐Nogueira · 2022 · World Journal of Gastroenterology
Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments
Zuyin Li, Gang Wu, Chen Qiu, Zhi-Jie Zhou, Yupeng Wang, Guohe Song, Chao Xiao, Xin Zhang, Guilong Deng, Ruitao Wang et al. · 2022 · World Journal of Gastroenterology
Associations of TM6SF2 167K allele with liver enzymes and lipid profile in children: the PANIC Study
Anna Viitasalo, Jussi Pihlajamäki, Jussi Paananen, Mustafa Atalay, Virpi Lindi, Timo Antero Lakka · 2016 · Pediatric Research
Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum
Federica Tavaglione, Giovanni Targher, Luca V. C. Valenti, Stefano Romeo · 2020 · Endocrinology Diabetes & Metabolism
PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age
Renáta Šenkeříková, Soňa Fraňková, Milan Jirsa, Miluše Kreidlová, Dušan Merta, Magdaléna Neřoldová, Klara Chmelova, Julius Špičák, Jan Šperl · 2019 · PLoS ONE
MAFLD and Celiac Disease in Children
Serena Scapaticci, Annamaria Venanzi, Francesco Chiarelli, Cosimo Giannini · 2023 · International Journal of Molecular Sciences
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Causation or Association
Atul Deep Bali, Akiva Rosenzveig, William H. Frishman, Wilbert S. Aronow · 2023 · Cardiology in Review
Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study
Francesco Tovoli, Bernardo Stefanini, Daniele Mandrioli, Stefano Mattioli, Andrea Vornoli, Daria Sgargi, Fabiana Manservisi, Fabio Piscaglia, Stefania Curti, Luigi Bolondi · 2023 · Digestive and Liver Disease
Evaluation of antisense oligonucleotide therapy targeting Hsd17b13 in a fibrosis mice model
Yanling Ma, Hong Cai, Julia Anne Smith, Ching-Hsuen Chu, Stephen E. Mercer, Stephanie Boehm, Ivar M. McDonald, Bradley A. Zinker, Dong Cheng · 2024 · Journal of Lipid Research
Altered lipid metabolism and the development of metabolic-associated fatty liver disease
Christy Foster, Charles A Gagnon, Ambika P. Ashraf · 2024 · Current Opinion in Lipidology